VTE Flashcards

1
Q

The VTE protocol should be developed by an interdisciplinary team including?

A

a clinical team leader;

a quality improvement facilitator;

process owners, including frontline personnel from each discipline (eg, pharmacists, RNs, surgeons, anesthesia professionals);

information technology and health information system experts; and

patient representatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The VTE protocol should

A

be evidence-based;

standardize assessment of VTE and bleeding risk;

provide clinical decision support for evidence-based prophylaxis based on level of risk for VTE and bleeding at critical phases of care (eg, admission, transfer of care, post surgery); and

be easy to use in clinical practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Protocols for VTE prevention establish best practice at the local level

A

Include a standardized VTE risk assessment model.
Include a standardized bleeding risk assessment model.
Include a start time (eg, upon admission, before surgery, after surgery) for all types of prophylaxis based on the clinical condition of the patient.
The VTE protocol may include specialty- or procedure-specific (eg, orthopedic, cardiac) clinical decision support for prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Assess the patient for the following VTE risk factors that contribute to venous stasis, vessel wall injury, and hypercoagulability

A
  1. age greater than 40 years
  2. cancer (ie, active or occult) or cancer treatment
  3. obesity
  4. previous history of VTE or stroke
  5. prolonged bed rest (> 3 days) or immobilization
  6. varicose veins
  7. presence of a central venous catheter
  8. trauma
  9. spinal cord injury
  10. inherited or acquired thrombophilia
  11. estrogen therapy (ie, oral contraceptive, hormone replacement therapy)
  12. critical care admission
  13. dehydration
  14. comorbidities, including

heart disease (eg, congestive heart failure, hypertension, pacemaker),

  1. metabolic or endocrine disease (eg, Cushing’s disease),
  2. respiratory disease (eg, chronic obstructive pulmonary disease),
  3. acute infectious disease(eg, sepsis, and

inflammatory conditions (eg, inflammatory bowel disease,rheumatoid arthritis,psoriasis

pregnancy and the postpartum period

smoking

steroid therapy

American Society of Anesthesiologists physical status classification of 3 or higher

recent surgery (ie, within 30 days)

preoperative hospitalization

blood transfusion

known non-O blood type

obstructive sleep apnea and

asplenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

*Assess the patient for procedure-related VTE risk factors, including

A
  1. duration of surgery (ie, surgery and general anesthesia time longer than 90 minutes or longer than 60 minutes for procedures involving the lower limb or pelvis
  2. the intraoperative patient position (eg, excessive hip flexion, hyperextension of the knee, reverse Trendelenburg)
  3. use of a pneumatic tourniquet, especially during prolonged periods of inflation
  4. major orthopedic surgery (eg, hip arthroplasty, knee arthroplasty, hip fracture surgery)
  5. bariatric surgery
  6. cardiothoracic surgery
  7. vascular surgery
  8. general surgery involving the abdomen or pelvis (eg, hepatic resection
  9. urologic surgery involving the abdomen or pelvis (eg, nephrectomy)
  10. neurosurgery
  11. spine surgery
  12. immobilizing cast of a lower limb
  13. open procedure
  14. emergency procedure
  15. concurrent procedures
  16. transplant surgery
  17. cesarean delivery
  18. major foot and ankle surgery (eg, Achilles tendon rupture, total ankle arthroplasty, ankle fracture;
  19. major hand, wrist, or elbow surgery (eg, elbow arthroplasty)
  20. procedures involving hardware placement
  21. major plastic surgery (eg, body contouring, abdominoplasty, breast reconstruction)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When prescribed, verify that intermittent pneumatic compression devices are functioning and graduated compression stockings are applied before the administration of ?

A

regional or general anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When prescribed, verify that intermittent pneumatic compression devices are functioning and graduated compression stockings are applied before the administration of ?

A

regional or general anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

*Assess the patient for potential contraindications related to use of the intermittent pneumatic compression device, including

A

any leg condition (eg, dermatitis, recent skin graft, gangrene) that pneumatic compression may exacerbate,2,48

known allergy or sensitivity to the sleeve or tubing material,48

cardiac failure or pulmonary edema from congestive heart failure,48,220

any factor that prevents correct fitting of sleeves (eg, exceeding the size limit, severe leg edema, deformity),48,231

pre-existing DVT, and

severe arteriosclerosis or other ischemic vascular disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When the manufacturer’s instructions for use require the use of stockinet, graduated compression stockings, or other material under the sleeves, verify that the material is

A

wrinkle-free when applied to the skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

During application of the sleeve, place the tubing on

A

the external surface of the sleeve facing away from the patient’s skin and away from locations that may create a pressure injury.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Verify that the sleeves for intermittent pneumatic compression devices are applied correctly, connected to the device pump, and operating and that the tubing is

A

away from locations that may create a pressure injury after the patient is transferred to the OR bed or repositioned.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When intermittent pneumatic compression is used, implement interventions to prevent unplanned hypothermia as recommended in

A

the AORN Guideline for Prevention of Unplanned Patient Hypothermia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sleeves for intermittent pneumatic compression devices used on the sterile field should be

A

sterile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

*Apply graduated compression stockings according to the manufacturer’s written instructions. After application, verify that the

A

stockings are not rolled up the foot or down the leg,

stockings are smooth when fitted,

toe holes lie underneath the toes,

heel patches are in the correct position, and

thigh gussets are positioned on the patient’s inner thighs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The intermittent pneumatic compression device should remain on for a minimum of how long daily during the intraoperative and immediate postoperative period unless removal is necessitated by patient care needs

A

18 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Assess the patient for potential contraindications related to use of pharmacologic VTE prophylaxis, including

A

active bleeding2,48,270;

previous major bleeding2,143,270,271;

known, untreated bleeding disorder2,48,270;

severe renal or hepatic failure2,48,143,270,271;

thrombocytopenia2,48,270,271;

acute stroke2,48;

uncontrolled systemic hypertension2,48,270,271;

lumbar puncture or epidural or spinal anesthesia within the previous 4 hours or planned within the next 12 hours2,48,270-272;

concomitant use of anticoagulants, antiplatelet therapy, or thrombolytic drugs2,48,143,270,271;

procedures in which bleeding complications may have especially severe consequences (eg, craniotomy, spinal surgery, spinal trauma, reconstructive procedures involving a free flap)2,270;

bacterial endocarditis270,271;

allergy to medication271;

pregnancy270;

ophthalmic surgery270; and

prosthetic heart valve.270

17
Q

Assess the patient for adverse effects related to the use of pharmacologic VTE prophylaxis, including

A

bleeding2,270,271;

hematoma formation2,270;

thrombocytopenia2,270,271;

osteoporosis and osteopenia271;

skin necrosis270,273;

calciphylaxis270;

atheroembolism270; and

injection site irritation, pa

18
Q

Include the following in the quality assurance and performance improvement program for VTE prevention:

A

monitoring the rate of perioperative venous thromboembolism, including DVT and PE4,307,308;

assessing compliance with prophylaxis according to the health care organization’s VTE prevention protocol4;

addressing barriers to compliance with prophylaxis, including complications from prophylaxis use4;

identifying common failure modes in VTE prevention processes4; and

providing ongoing evaluation, feedback to perioperative team members, and refinement of the VTE protocol as needed.4